MYL
$14.35
Mylan NV Ord Shs
($.02)
(.14%)
MYL
Earnings Whisper ®
N/A
3rd Quarter September 2020
Consensus:  $1.13
Revenue:  $2.98 Bil
Thursday
Nov 5
6:30 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when MYL reports earnings?
Beat
Meet
Miss

Where is MYL's stock price going from here?
Up
Flat
Down
Stock chart of MYL
Analysts
Summary of analysts' recommendations for MYL
Score
Grade
Pivots
Resistance
$15.29
$15.08
$14.73

$14.52

Support
$14.16
$13.95
$13.60
Tweet
Growth
Description
Mylan NV is a pharmaceutical company. The company develops, licenses, manufactures, markets and distributes generic and specialty pharmaceuticals. It operates primarily in the United States, Canada, Europe, the Middle East, Africa, India, Australia, Japan and New Zealand. Mylan NV, formerly known as Mylan Inc., is based in Canonsburg, Pennsylvania.
Peers
InterCeptRegeneron PharmaceuticalsBioMarin PharmaceuticalVertex PharmaceuticalsJohnson & JohnsonZoetisUltragenyx PharmaceuticalBristol-Myers SquibbCatalentMerck & Co.